We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
-3.25%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$6.01B
AUM Growth
+$262M
Cap. Flow
-$162M
Cap. Flow %
-2.7%
Top 10 Hldgs %
51.52%
Holding
592
New
224
Increased
125
Reduced
42
Closed
159

Top Buys

Rank Stock Value
1
WAY
Waystar Holding Corp
WAY
+$107M
2
GILD icon
Gilead Sciences
GILD
+$99.5M
3
CVS icon
CVS Health
CVS
+$61M
4
BAX icon
Baxter International
BAX
+$57.9M
5
CGEM icon
Cullinan Oncology
CGEM
+$45.6M

Top Sells

Rank Stock Value
1
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
+$136M
2
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
+$80.7M
3
SWTX
SpringWorks Therapeutics
SWTX
+$63.2M
4
OSCR icon
Oscar Health
OSCR
+$44.4M
5
VKTX icon
Viking Therapeutics
VKTX
+$38M

Sector Composition

Rank Sector Weight
1 Healthcare 83.29%
2 Industrials 0.69%
3 Technology 0.57%
4 Financials 0.44%
5 Consumer Discretionary 0.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SYBT icon
551
Stock Yards Bancorp
SYBT
$2.41B
– –
-9,821
Closed -$480K
T icon
552
AT&T
T
$167B
– –
-19,441
Closed -$342K
TERN
553
DELISTED
Terns Pharmaceuticals
TERN
– –
-24,060
Closed -$158K
THRM icon
554
Gentherm
THRM
$1.28B
– –
-5,557
Closed -$320K
TIPT icon
555
Tiptree Inc
TIPT
$670M
– –
-16,728
Closed -$289K
TRNO icon
556
Terreno Realty
TRNO
$7.68B
– –
-4,954
Closed -$329K
UE icon
557
Urban Edge Properties
UE
$2.95B
– –
-14,991
Closed -$259K
V icon
558
Visa
V
$690B
– –
-2,137
Closed -$596K
VCYT icon
559
Veracyte
VCYT
$4.48B
– –
-10,011
Closed -$222K
VERV
560
DELISTED
Verve Therapeutics
VERV
– –
-11,504
Closed -$153K
VIGL
561
DELISTED
Vigil Neuroscience
VIGL
– –
-980,311
Closed -$3.34M
VKTX icon
562
Viking Therapeutics
VKTX
$4.08B
– –
-463,501
Closed -$38M
VSTM icon
563
Verastem
VSTM
$555M
– –
-1,538,461
Closed -$18.2M
VYGR icon
564
Voyager Therapeutics
VYGR
$184M
– –
-32,005
Closed -$298K
W icon
565
Wayfair
W
$12.2B
– –
-6,296
Closed -$427K
WEAV icon
566
Weave Communications
WEAV
$528M
– –
-11,989
Closed -$138K
WGS icon
567
GeneDx Holdings
WGS
$1.81B
– –
-643,110
Closed -$5.87M
WINT
568
DELISTED
Windtree Therapeutics
WINT
– –
-676
Closed -$215K
WRB icon
569
W.R. Berkley
WRB
$28B
– –
-4,568
Closed -$269K
WW
570
DELISTED
WW International
WW
– –
-14,549
Closed -$26.9K
XERS icon
571
Xeris Biopharma Holdings
XERS
$1.46B
– –
-73,570
Closed -$163K
XNCR icon
572
Xencor
XNCR
$1.48B
– –
-18,968
Closed -$420K
XRX icon
573
Xerox
XRX
$360M
– –
-11,607
Closed -$208K
ZD icon
574
Ziff Davis
ZD
$1.95B
– –
-7,637
Closed -$481K
ZEUS
575
DELISTED
Olympic Steel
ZEUS
– –
-6,194
Closed -$439K
20 21 22
23
24

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q2 2024 Portfolio in Review

As of Q2 2024, Deerfield Management held 592 positions worth $6.01B, up 4.6% from $5.75B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Deerfield Management's Q2 2024 filing shows 224 new, 125 increased, 42 reduced and 159 closed positions. Its largest new stake was Waystar Holding Corp: 4,952,004 shares worth $106M. The largest sale was Fusion Pharmaceuticals Inc. Common Shares, an estimated $136M.

By sector, the portfolio is most concentrated in Healthcare at 83% of assets, down from 89% a quarter earlier, followed by Industrials and Technology.

  • Deerfield Management's largest Q2 2024 buy was Waystar Holding Corp: 4,952,004 shares worth $106M.
  • Deerfield Management added most to Baxter International in Q2 2024, an estimated $57.9M increase.
  • Deerfield Management's biggest Q2 2024 reduction was Oscar Health, cutting an estimated $44.4M.
  • Deerfield Management fully exited Fusion Pharmaceuticals Inc. Common Shares in Q2 2024, selling an estimated $136M.
  • Deerfield Management's ten largest holdings make up 52% of its $6.01B portfolio in Q2 2024.
  • Deerfield Management opened 224 new positions and closed 159 in Q2 2024.
  • Deerfield Management's portfolio value rose 4.6% quarter-over-quarter to $6.01B.

Based on Deerfield Management's 13F filing for Q2 2024, filed 14 Aug 2024.